Have a feature idea you'd love to see implemented?
Let us know!
CELU Celularity Inc
Price (delayed)
$2.85
Market cap
$62.66M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.45
Enterprise value
$119.46M
Highlights
CELU's revenue has soared by 182% year-on-year and by 27% since the previous quarter
The gross profit is up by 46% since the previous quarter
The company's net income fell by 36% YoY but it rose by 27% QoQ
Celularity's EPS has increased by 31% QoQ but it has decreased by 13% YoY
CELU's equity has dropped by 77% year-on-year and by 11% since the previous quarter
The quick ratio has declined by 17% since the previous quarter
Key stats
What are the main financial stats of CELU
Market
Valuations
Earnings
Shares outstanding
21.98M
Market cap
$62.66M
Enterprise value
$119.46M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.99
Price to sales (P/S)
1.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.8
Revenue
$42.69M
EBIT
-$108.49M
EBITDA
-$99.58M
Free cash flow
-$21.39M
Per share
Balance sheet
Liquidity
EPS
-$5.45
Free cash flow per share
-$0.98
Book value per share
$1.44
Revenue per share
$1.95
TBVPS
$5.41
Total assets
$135.49M
Total liabilities
$107.68M
Debt
$67.36M
Equity
$27.81M
Working capital
-$50.17M
Debt to equity
2.42
Current ratio
0.26
Quick ratio
0.35
Net debt/EBITDA
-0.57
Margins
Efficiency
Dividend
EBITDA margin
-233.3%
Gross margin
58.1%
Net margin
-264.3%
Operating margin
-242.4%
Return on assets
-77.8%
Return on equity
-346.5%
Return on invested capital
-99.9%
Return on capital employed
-160.5%
Return on sales
-254.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CELU stock price
How has the Celularity stock price performed over time
Intraday
-3.06%
1 week
26.67%
1 month
35.39%
1 year
39.02%
YTD
15.38%
QTD
-4.04%
Financial performance
How have Celularity's revenue and profit performed over time
Revenue
$42.69M
Gross profit
$24.8M
Operating income
-$103.49M
Net income
-$112.83M
Gross margin
58.1%
Net margin
-264.3%
CELU's revenue has soared by 182% year-on-year and by 27% since the previous quarter
Celularity's operating margin has surged by 87% YoY and by 63% QoQ
Celularity's operating income has soared by 64% YoY and by 53% from the previous quarter
CELU's net margin has surged by 52% year-on-year and by 43% since the previous quarter
Growth
What is Celularity's growth rate over time
Valuation
What is Celularity stock price valuation
P/E
N/A
P/B
1.99
P/S
1.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.8
Celularity's EPS has increased by 31% QoQ but it has decreased by 13% YoY
CELU's equity has dropped by 77% year-on-year and by 11% since the previous quarter
CELU's revenue has soared by 182% year-on-year and by 27% since the previous quarter
CELU's P/S is 89% below its 5-year quarterly average of 13.5 and 39% below its last 4 quarters average of 2.4
Efficiency
How efficient is Celularity business performance
CELU's return on invested capital has dropped by 59% year-on-year but it is up by 25% since the previous quarter
Celularity's return on sales has surged by 53% YoY and by 43% QoQ
The return on equity has declined by 24% since the previous quarter
CELU's ROA is up by 13% since the previous quarter
Dividends
What is CELU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CELU.
Financial health
How did Celularity financials performed over time
CELU's total assets is 26% greater than its total liabilities
CELU's total assets is down by 45% year-on-year and by 6% since the previous quarter
Celularity's current ratio has decreased by 26% QoQ and by 7% YoY
CELU's debt is 142% greater than its equity
CELU's equity has dropped by 77% year-on-year and by 11% since the previous quarter
The debt to equity has grown by 15% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.